{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:53:35Z","timestamp":1791852815710,"version":"4.3.4"},"reference-count":183,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100012659","name":"Foundation for Innovative Research Groups of the National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330083"],"award-info":[{"award-number":["82330083"]}],"id":[{"id":"10.13039\/501100012659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"DOI":"10.1186\/s12964-026-03080-y","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T07:53:59Z","timestamp":1784274839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Notch receptors in breast cancer: context-dependent roles and therapeutic targeting"],"prefix":"10.1186","volume":"24","author":[{"given":"Mei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-9896-4404","authenticated-orcid":false,"given":"Qinong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"issue":"3","key":"3080_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"3080_CR2","doi-asserted-by":"publisher","unstructured":"Carvalho E, Canberk S, Schmitt F, Vale N. Molecular Subtypes and Mechanisms of Breast Cancer: Precision Medicine Approaches for Targeted Therapies. Cancers (Basel). 2025;17(7). https:\/\/doi.org\/10.3390\/cancers17071102.","DOI":"10.3390\/cancers17071102"},{"key":"3080_CR3","doi-asserted-by":"crossref","unstructured":"Morgan TH. The Theory of the Gene. The American Naturalist. 1917;51(609):513\u2009\u2013\u200944. doi: 10.1086\/279629%\/ The University of Chicago Press.","DOI":"10.1086\/279629"},{"key":"3080_CR4","doi-asserted-by":"publisher","unstructured":"Artavanis-Tsakonas S, Muskavitch MA, Yedvobnick B. Molecular cloning of Notch, a locus affecting neurogenesis in Drosophila melanogaster. Proceedings of the National Academy of SciencesProceedings of the National Academy of Sciences. 1983;80(7):1977-81. https:\/\/doi.org\/10.1073\/pnas.80.7.1977% Proceedings of the National Academy of Sciences.","DOI":"10.1073\/pnas.80.7.1977%"},{"key":"3080_CR5","doi-asserted-by":"publisher","first-page":"2415489","DOI":"10.1155\/2018\/2415489","volume":"2018","author":"EN Kontomanolis","year":"2018","unstructured":"Kontomanolis EN, Kalagasidou S, Pouliliou S, Anthoulaki X, Georgiou N, Papamanolis V, et al. The Notch Pathway in Breast Cancer Progression. ScientificWorldJournal. 2018;2018:2415489. https:\/\/doi.org\/10.1155\/2018\/2415489.","journal-title":"ScientificWorldJournal"},{"key":"3080_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-3-030-55031-8_12","volume":"1287","author":"Q Shen","year":"2021","unstructured":"Shen Q, Reedijk M. Notch Signaling and the Breast Cancer Microenvironment. Adv Exp Med Biol. 2021;1287:183\u2013200. https:\/\/doi.org\/10.1007\/978-3-030-55031-8_12.","journal-title":"Adv Exp Med Biol"},{"key":"3080_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.2147\/bctt.S376873","volume":"14","author":"N Jiang","year":"2022","unstructured":"Jiang N, Hu Y, Wang M, Zhao Z, Li M. The Notch Signaling Pathway Contributes to Angiogenesis and Tumor Immunity in Breast Cancer. Breast Cancer (Dove Med Press). 2022;14:291\u2013309. https:\/\/doi.org\/10.2147\/bctt.S376873.","journal-title":"Breast Cancer (Dove Med Press)"},{"issue":"1","key":"3080_CR8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/s41389-025-00545-6","volume":"14","author":"WC Chung","year":"2025","unstructured":"Chung WC, Wang W, Challagundla L, Moore CD, Egan SE, Xu K. Subtype-specific role for Jagged1 in promoting or inhibiting breast tumor formation. Oncogenesis. 2025;14(1):2. https:\/\/doi.org\/10.1038\/s41389-025-00545-6.","journal-title":"Oncogenesis"},{"issue":"2","key":"3080_CR9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41419-023-05674-7","volume":"14","author":"S Brahim","year":"2023","unstructured":"Brahim S, Negulescu A-M, Geneste C, Schott T, Lin S, Morel L-O, et al. Notch3 regulates Mybl2 via HeyL to limit proliferation and tumor initiation in breast cancer. Cell Death Dis. 2023;14(2):171. https:\/\/doi.org\/10.1038\/s41419-023-05674-7.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3080_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-024-01828-x","volume":"9","author":"Q Shi","year":"2024","unstructured":"Shi Q, Xue C, Zeng Y, Yuan X, Chu Q, Jiang S, et al. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies. Signal Transduct Target Ther. 2024;9(1):128. https:\/\/doi.org\/10.1038\/s41392-024-01828-x.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"3080_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1006\/mcne.1997.0612","volume":"9","author":"G Weinmaster","year":"1997","unstructured":"Weinmaster G. The ins and outs of notch signaling. Mol Cell Neurosci. 1997;9(2):91\u2013102. https:\/\/doi.org\/10.1006\/mcne.1997.0612.","journal-title":"Mol Cell Neurosci"},{"issue":"2","key":"3080_CR12","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1006\/geno.1993.1055","volume":"15","author":"FF del Amo","year":"1993","unstructured":"del Amo FF, Gendron-Maguire M, Swiatek PJ, Jenkins NA, Copeland NG, Gridley T. Cloning, analysis, and chromosomal localization of Notch-1, a mouse homolog of Drosophila Notch. Genomics. 1993;15(2):259\u201364. https:\/\/doi.org\/10.1006\/geno.1993.1055.","journal-title":"Genomics"},{"issue":"4","key":"3080_CR13","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1242\/dev.116.4.931","volume":"116","author":"G Weinmaster","year":"1992","unstructured":"Weinmaster G, Roberts VJ, Lemke G. Notch2: a second mammalian Notch gene. Development. 1992;116(4):931\u201341. https:\/\/doi.org\/10.1242\/dev.116.4.931.","journal-title":"Development"},{"issue":"2","key":"3080_CR14","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0925-4773(94)90081-7","volume":"46","author":"M Lardelli","year":"1994","unstructured":"Lardelli M, Dahlstrand J, Lendahl U. The novel Notch homologue mouse Notch 3 lacks specific epidermal growth factor-repeats and is expressed in proliferating neuroepithelium. Mech Dev. 1994;46(2):123\u201336. https:\/\/doi.org\/10.1016\/0925-4773(94)90081-7.","journal-title":"Mech Dev"},{"issue":"7","key":"3080_CR15","doi-asserted-by":"publisher","first-page":"2251","DOI":"10.1242\/dev.122.7.2251","volume":"122","author":"H Uyttendaele","year":"1996","unstructured":"Uyttendaele H, Marazzi G, Wu G, Yan Q, Sassoon D, Kitajewski J. Notch4\/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 1996;122(7):2251\u20139. https:\/\/doi.org\/10.1242\/dev.122.7.2251.","journal-title":"Development"},{"issue":"4","key":"3080_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/0092-8674(91)90064-6","volume":"67","author":"I Rebay","year":"1991","unstructured":"Rebay I, Fleming RJ, Fehon RG, Cherbas L, Cherbas P, Artavanis-Tsakonas S. Specific EGF repeats of Notch mediate interactions with Delta and Serrate: implications for Notch as a multifunctional receptor. Cell. 1991;67(4):687\u201399. https:\/\/doi.org\/10.1016\/0092-8674(91)90064-6.","journal-title":"Cell"},{"issue":"6","key":"3080_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1242\/dev.127.6.1291","volume":"127","author":"JF de Celis","year":"2000","unstructured":"de Celis JF, Bray SJ. The Abruptex domain of Notch regulates negative interactions between Notch, its ligands and Fringe. Development. 2000;127(6):1291\u2013302. https:\/\/doi.org\/10.1242\/dev.127.6.1291.","journal-title":"Development"},{"issue":"7","key":"3080_CR18","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1016\/j.bbamcr.2014.03.015","volume":"1843","author":"AC James","year":"2014","unstructured":"James AC, Szot JO, Iyer K, Major JA, Pursglove SE, Chapman G, et al. Notch4 reveals a novel mechanism regulating Notch signal transduction. Biochim Biophys Acta. 2014;1843(7):1272\u201384. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.03.015.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3080_CR19","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.devcel.2016.12.013","volume":"40","author":"S Kakuda","year":"2017","unstructured":"Kakuda S, Haltiwanger RS. Deciphering the Fringe-Mediated Notch Code: Identification of Activating and Inhibiting Sites Allowing Discrimination between Ligands. Dev Cell. 2017;40(2):193\u2013201. https:\/\/doi.org\/10.1016\/j.devcel.2016.12.013.","journal-title":"Dev Cell"},{"issue":"2","key":"3080_CR20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.bbrc.2014.05.115","volume":"453","author":"H Takeuchi","year":"2014","unstructured":"Takeuchi H, Haltiwanger RS. Significance of glycosylation in Notch signaling. Biochem Biophys Res Commun. 2014;453(2):235\u201342. https:\/\/doi.org\/10.1016\/j.bbrc.2014.05.115.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"3080_CR21","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/j.ccr.2012.03.041","volume":"21","author":"K Xu","year":"2012","unstructured":"Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, et al. Lunatic fringe deficiency cooperates with the Met\/Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell. 2012;21(5):626\u201341. https:\/\/doi.org\/10.1016\/j.ccr.2012.03.041.","journal-title":"Cancer Cell"},{"key":"3080_CR22","doi-asserted-by":"publisher","first-page":"e02950","DOI":"10.7554\/eLife.02950","volume":"3","author":"L LeBon","year":"2014","unstructured":"LeBon L, Lee TV, Sprinzak D, Jafar-Nejad H, Elowitz MB. Fringe proteins modulate Notch-ligand cis and trans interactions to specify signaling states. Elife. 2014;3:e02950. https:\/\/doi.org\/10.7554\/eLife.02950.","journal-title":"Elife"},{"key":"3080_CR23","doi-asserted-by":"publisher","unstructured":"Kuintzle R, Santat LA, Elowitz MB. Diversity in Notch ligand-receptor signaling interactions. Elife. 2025;12. https:\/\/doi.org\/10.7554\/eLife.91422.","DOI":"10.7554\/eLife.91422"},{"issue":"10","key":"3080_CR24","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1158\/0008-5472.Can-14-3303","volume":"75","author":"S Zhang","year":"2015","unstructured":"Zhang S, Chung WC, Wu G, Egan SE, Miele L, Xu K. Manic fringe promotes a claudin-low breast cancer phenotype through notch-mediated PIK3CG induction. Cancer Res. 2015;75(10):1936\u201343. https:\/\/doi.org\/10.1158\/0008-5472.Can-14-3303.","journal-title":"Cancer Res"},{"issue":"11","key":"3080_CR25","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1242\/dev.108100","volume":"141","author":"J Petrovic","year":"2014","unstructured":"Petrovic J, Formosa-Jordan P, Luna-Escalante JC, Abell\u00f3 G, Iba\u00f1es M, Neves J, et al. Ligand-dependent Notch signaling strength orchestrates lateral induction and lateral inhibition in the developing inner ear. Development. 2014;141(11):2313\u201324. https:\/\/doi.org\/10.1242\/dev.108100.","journal-title":"Development"},{"issue":"4","key":"3080_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.01.002","volume":"172","author":"N Nandagopal","year":"2018","unstructured":"Nandagopal N, Santat LA, LeBon L, Sprinzak D, Bronner ME, Elowitz MB. Dynamic Ligand Discrimination in the Notch Signaling Pathway. Cell. 2018;172(4):869\u2013e8019. https:\/\/doi.org\/10.1016\/j.cell.2018.01.002.","journal-title":"Cell"},{"issue":"4","key":"3080_CR27","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nsmb1227","volume":"14","author":"WR Gordon","year":"2007","unstructured":"Gordon WR, Vardar-Ulu D, Histen G, Sanchez-Irizarry C, Aster JC, Blacklow SC. Structural basis for autoinhibition of Notch. Nat Struct Mol Biol. 2007;14(4):295\u2013300. https:\/\/doi.org\/10.1038\/nsmb1227.","journal-title":"Nat Struct Mol Biol"},{"issue":"6","key":"3080_CR28","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.devcel.2015.05.004","volume":"33","author":"WR Gordon","year":"2015","unstructured":"Gordon WR, Zimmerman B, He L, Miles LJ, Huang J, Tiyanont K, et al. Mechanical Allostery: Evidence for a Force Requirement in the Proteolytic Activation of Notch. Dev Cell. 2015;33(6):729\u201336. https:\/\/doi.org\/10.1016\/j.devcel.2015.05.004.","journal-title":"Dev Cell"},{"key":"3080_CR29","doi-asserted-by":"publisher","unstructured":"Kovall RA, Blacklow SC. Mechanistic insights into Notch receptor signaling from structural and biochemical studies. Curr Top Dev Biol. 2010;92:31\u201371. https:\/\/doi.org\/10.1016\/S0070-2153(10)92002-4.","DOI":"10.1016\/S0070-2153(10)92002-4"},{"issue":"28","key":"3080_CR30","doi-asserted-by":"publisher","first-page":"43220","DOI":"10.18632\/oncotarget.9215","volume":"7","author":"NM Santio","year":"2016","unstructured":"Santio NM, Landor SK, Vahtera L, Yl\u00e4-Pelto J, Paloniemi E, Imanishi SY, et al. Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells. Oncotarget. 2016;7(28):43220\u201338. https:\/\/doi.org\/10.18632\/oncotarget.9215.","journal-title":"Oncotarget"},{"key":"3080_CR31","doi-asserted-by":"publisher","first-page":"100593","DOI":"10.1016\/j.jbc.2021.100593","volume":"296","author":"SKJ Landor","year":"2021","unstructured":"Landor SKJ, Santio NM, Eccleshall WB, Paramonov VM, Gagliani EK, Hall D, et al. PIM-induced phosphorylation of Notch3 promotes breast cancer tumorigenicity in a CSL-independent fashion. J Biol Chem. 2021;296:100593. https:\/\/doi.org\/10.1016\/j.jbc.2021.100593.","journal-title":"J Biol Chem"},{"issue":"1\u20132","key":"3080_CR32","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/s0925-4773(01)00373-2","volume":"104","author":"P Beatus","year":"2001","unstructured":"Beatus P, Lundkvist J, Oberg C, Pedersen K, Lendahl U. The origin of the ankyrin repeat region in Notch intracellular domains is critical for regulation of HES promoter activity. Mech Dev. 2001;104(1\u20132):3\u201320. https:\/\/doi.org\/10.1016\/s0925-4773(01)00373-2.","journal-title":"Mech Dev"},{"issue":"6","key":"3080_CR33","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1101\/gad.227496.113","volume":"28","author":"DM Gerhardt","year":"2014","unstructured":"Gerhardt DM, Pajcini KV, D\u2019Altri T, Tu L, Jain R, Xu L, et al. The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes Dev. 2014;28(6):576\u201393. https:\/\/doi.org\/10.1101\/gad.227496.113.","journal-title":"Genes Dev"},{"issue":"20","key":"3080_CR34","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.1128\/mcb.20.20.7505-7515.2000","volume":"20","author":"JC Aster","year":"2000","unstructured":"Aster JC, Xu L, Karnell FG, Patriub V, Pui JC, Pear WS. Essential roles for ankyrin repeat and transactivation domains in induction of T-cell leukemia by notch1. Mol Cell Biol. 2000;20(20):7505\u201315. https:\/\/doi.org\/10.1128\/mcb.20.20.7505-7515.2000.","journal-title":"Mol Cell Biol"},{"issue":"14","key":"3080_CR35","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1242\/dev.125492","volume":"142","author":"Z Liu","year":"2015","unstructured":"Liu Z, Brunskill E, Varnum-Finney B, Zhang C, Zhang A, Jay PY, et al. The intracellular domains of Notch1 and Notch2 are functionally equivalent during development and carcinogenesis. Development. 2015;142(14):2452\u201363. https:\/\/doi.org\/10.1242\/dev.125492.","journal-title":"Development"},{"issue":"4","key":"3080_CR36","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.molcel.2004.10.014","volume":"16","author":"CJ Fryer","year":"2004","unstructured":"Fryer CJ, White JB, Jones KA. Mastermind recruits CycC:CDK8 to phosphorylate the Notch ICD and coordinate activation with turnover. Mol Cell. 2004;16(4):509\u201320. https:\/\/doi.org\/10.1016\/j.molcel.2004.10.014.","journal-title":"Mol Cell"},{"issue":"16","key":"3080_CR37","doi-asserted-by":"publisher","first-page":"6261","DOI":"10.1128\/mcb.02478-05","volume":"26","author":"MY Chiang","year":"2006","unstructured":"Chiang MY, Xu ML, Histen G, Shestova O, Roy M, Nam Y, et al. Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1. Mol Cell Biol. 2006;26(16):6261\u201371. https:\/\/doi.org\/10.1128\/mcb.02478-05.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"3080_CR38","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1038\/ncb2028","volume":"12","author":"T Ishitani","year":"2010","unstructured":"Ishitani T, Hirao T, Suzuki M, Isoda M, Ishitani S, Harigaya K, et al. Nemo-like kinase suppresses Notch signalling by interfering with formation of the Notch active transcriptional complex. Nat Cell Biol. 2010;12(3):278\u201385. https:\/\/doi.org\/10.1038\/ncb2028.","journal-title":"Nat Cell Biol"},{"issue":"7346","key":"3080_CR39","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature09917","volume":"473","author":"V Guarani","year":"2011","unstructured":"Guarani V, Deflorian G, Franco CA, Kr\u00fcger M, Phng LK, Bentley K, et al. Acetylation-dependent regulation of endothelial Notch signalling by the SIRT1 deacetylase. Nature. 2011;473(7346):234\u20138. https:\/\/doi.org\/10.1038\/nature09917.","journal-title":"Nature"},{"issue":"38","key":"3080_CR40","doi-asserted-by":"publisher","first-page":"35847","DOI":"10.1074\/jbc.M103992200","volume":"276","author":"C Oberg","year":"2001","unstructured":"Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem. 2001;276(38):35847\u201353. https:\/\/doi.org\/10.1074\/jbc.M103992200.","journal-title":"J Biol Chem"},{"issue":"369","key":"3080_CR41","doi-asserted-by":"publisher","first-page":"ra30","DOI":"10.1126\/scisignal.2005892","volume":"8","author":"K Hein","year":"2015","unstructured":"Hein K, Mittler G, Cizelsky W, K\u00fchl M, Ferrante F, Liefke R, et al. Site-specific methylation of Notch1 controls the amplitude and duration of the Notch1 response. Sci Signal. 2015;8(369):ra30. https:\/\/doi.org\/10.1126\/scisignal.2005892.","journal-title":"Sci Signal"},{"issue":"9","key":"3080_CR42","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1016\/j.celrep.2016.04.070","volume":"15","author":"MR Broadus","year":"2016","unstructured":"Broadus MR, Chen TW, Neitzel LR, Ng VH, Jodoin JN, Lee LA, et al. Identification of a Paralog-Specific Notch1 Intracellular Domain Degron. Cell Rep. 2016;15(9):1920\u20139. https:\/\/doi.org\/10.1016\/j.celrep.2016.04.070.","journal-title":"Cell Rep"},{"issue":"5694","key":"3080_CR43","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1126\/science.1102160","volume":"306","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman LB, Sanchez-Irizarry C, et al. Activating Mutations of <\u2009i>NOTCH1\u2009in Human T Cell Acute Lymphoblastic Leukemia. Science. 2004;306(5694):269\u201371. https:\/\/doi.org\/10.1126\/science.1102160.","journal-title":"Science"},{"issue":"11","key":"3080_CR44","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1182\/blood.V104.11.4.4","volume":"104","author":"AP Weng","year":"2004","unstructured":"Weng AP, Ferrando AA, Lee W, Morris JP, Silverman IV, Sanchez-Irizarry LB. Gain-of-Function NOTCH1 Mutations Occur Frequently in Human T Cell Acute Lymphoblastic Leukemia. Blood. 2004;104(11):4. https:\/\/doi.org\/10.1182\/blood.V104.11.4.4.","journal-title":"Blood"},{"issue":"4","key":"3080_CR45","doi-asserted-by":"publisher","first-page":"e4947","DOI":"10.1002\/pro.4947","volume":"33","author":"KM Ramsey","year":"2024","unstructured":"Ramsey KM, Barrick D. Unraveling paralog-specific Notch signaling through thermodynamics of ternary complex formation and transcriptional activation of chimeric receptors. Protein Sci. 2024;33(4):e4947. https:\/\/doi.org\/10.1002\/pro.4947.","journal-title":"Protein Sci"},{"key":"3080_CR46","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1146\/annurev-biophys-101920-082204","volume":"50","author":"D Sprinzak","year":"2021","unstructured":"Sprinzak D, Blacklow SC. Biophysics of Notch Signaling. Annu Rev Biophys. 2021;50:157\u201389. https:\/\/doi.org\/10.1146\/annurev-biophys-101920-082204.","journal-title":"Annu Rev Biophys"},{"issue":"2","key":"3080_CR47","doi-asserted-by":"publisher","first-page":"e1012825","DOI":"10.1371\/journal.pcbi.1012825","volume":"21","author":"D Chen","year":"2025","unstructured":"Chen D, Liu X, Wang H, Merks RMH, Baker DA. A model of Notch signalling control of angiogenesis: Evidence of a role for Notch ligand heterodimerization. PLoS Comput Biol. 2025;21(2):e1012825. https:\/\/doi.org\/10.1371\/journal.pcbi.1012825.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"3080_CR48","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1038\/s41467-020-18860-4","volume":"11","author":"H Jiang","year":"2020","unstructured":"Jiang H, Zhou C, Zhang Z, Wang Q, Wei H, Shi W, et al. Jagged1-Notch1-deployed tumor perivascular niche promotes breast cancer stem cell phenotype through Zeb1. Nat Commun. 2020;11(1):5129. https:\/\/doi.org\/10.1038\/s41467-020-18860-4.","journal-title":"Nat Commun"},{"issue":"1","key":"3080_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13058-023-01628-1","volume":"25","author":"CL Duran","year":"2023","unstructured":"Duran CL, Karagiannis GS, Chen X, Sharma VP, Entenberg D, Condeelis JS, et al. Cooperative NF-\u03baB and Notch1 signaling promotes macrophage-mediated MenaINV expression in breast cancer. Breast Cancer Res. 2023;25(1):37. https:\/\/doi.org\/10.1186\/s13058-023-01628-1.","journal-title":"Breast Cancer Res"},{"key":"3080_CR50","doi-asserted-by":"publisher","first-page":"101615","DOI":"10.1016\/j.tranon.2022.101615","volume":"28","author":"J Pei","year":"2023","unstructured":"Pei J, Zhang S, Yang X, Han C, Pan Y, Li J, et al. Epigenetic regulator KDM4A activates Notch1-NICD-dependent signaling to drive tumorigenesis and metastasis in breast cancer. Transl Oncol. 2023;28:101615. https:\/\/doi.org\/10.1016\/j.tranon.2022.101615.","journal-title":"Transl Oncol"},{"key":"3080_CR51","doi-asserted-by":"publisher","first-page":"217534","DOI":"10.1016\/j.canlet.2025.217534","volume":"614","author":"H Chen","year":"2025","unstructured":"Chen H, Lin L, Qiao Z, Pei Y, Gao Y, Lou K, et al. YTHDF3 drives tumor growth and metastasis by recruiting eIF4B to promote Notch2 translation in breast cancer. Cancer Lett. 2025;614:217534. https:\/\/doi.org\/10.1016\/j.canlet.2025.217534.","journal-title":"Cancer Lett"},{"issue":"3","key":"3080_CR52","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s13402-022-00761-x","volume":"46","author":"M Chen","year":"2023","unstructured":"Chen M, Pan Y, Liu H, Ning F, Lu Q, Duan Y, et al. Ezrin accelerates breast cancer liver metastasis through promoting furin-like convertase-mediated cleavage of Notch1. Cell Oncol (Dordr). 2023;46(3):571\u201387. https:\/\/doi.org\/10.1007\/s13402-022-00761-x.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"3080_CR53","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1158\/0008-5472.Can-20-0360","volume":"81","author":"GY Jeong","year":"2021","unstructured":"Jeong GY, Park MK, Choi HJ, An HW, Park YU, Choi HJ, et al. NSD3-Induced Methylation of H3K36 Activates NOTCH Signaling to Drive Breast Tumor Initiation and Metastatic Progression. Cancer Res. 2021;81(1):77\u201390. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0360.","journal-title":"Cancer Res"},{"issue":"1","key":"3080_CR54","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1038\/s41467-022-28631-y","volume":"13","author":"S Zhang","year":"2022","unstructured":"Zhang S, Miyakawa A, Wickstr\u00f6m M, Dyberg C, Louhivuori L, Varas-Godoy M, et al. GIT1 protects against breast cancer growth through negative regulation of Notch. Nat Commun. 2022;13(1):1537. https:\/\/doi.org\/10.1038\/s41467-022-28631-y.","journal-title":"Nat Commun"},{"issue":"4","key":"3080_CR55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41418-019-0419-1","volume":"27","author":"S Shin","year":"2020","unstructured":"Shin S, Kim K, Kim HR, Ylaya K, Do SI, Hewitt SM, et al. Deubiquitylation and stabilization of Notch1 intracellular domain by ubiquitin-specific protease 8 enhance tumorigenesis in breast cancer. Cell Death Differ. 2020;27(4):1341\u201354. https:\/\/doi.org\/10.1038\/s41418-019-0419-1.","journal-title":"Cell Death Differ"},{"issue":"8","key":"3080_CR56","doi-asserted-by":"publisher","first-page":"e2206694120","DOI":"10.1073\/pnas.2206694120","volume":"120","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Lu YX, Liu F, Sang L, Shi C, Xie S, et al. lncRNA BREA2 promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1. Proc Natl Acad Sci U S A. 2023;120(8):e2206694120. https:\/\/doi.org\/10.1073\/pnas.2206694120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"3080_CR57","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s10020-022-00480-x","volume":"28","author":"LL Wang","year":"2022","unstructured":"Wang LL, Wan XY, Liu CQ, Zheng FM. NDR1 increases NOTCH1 signaling activity by impairing Fbw7 mediated NICD degradation to enhance breast cancer stem cell properties. Mol Med. 2022;28(1):49. https:\/\/doi.org\/10.1186\/s10020-022-00480-x.","journal-title":"Mol Med"},{"key":"3080_CR58","doi-asserted-by":"publisher","first-page":"101399","DOI":"10.1016\/j.tranon.2022.101399","volume":"20","author":"S Zhu","year":"2022","unstructured":"Zhu S, Wang X, Liu L, Ren G. Stabilization of Notch1 and \u03b2-catenin in response to ER- breast cancer-specific up-regulation of PSAT1 mediates distant metastasis. Transl Oncol. 2022;20:101399. https:\/\/doi.org\/10.1016\/j.tranon.2022.101399.","journal-title":"Transl Oncol"},{"issue":"5","key":"3080_CR59","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/s41418-025-01613-5","volume":"33","author":"S Zema","year":"2026","unstructured":"Zema S, Di Fazio F, Pelullo M, Di Savino S, Cerbelli B, Leopizzi M, et al. MAML1 drives Notch and Hedgehog oncogenic pathways by inhibiting Itch activity in triple-negative breast cancer. Cell Death Differ. 2026;33(5):971\u201387. https:\/\/doi.org\/10.1038\/s41418-025-01613-5.","journal-title":"Cell Death Differ"},{"issue":"4","key":"3080_CR60","doi-asserted-by":"publisher","first-page":"R54","DOI":"10.1186\/bcr3447","volume":"15","author":"V Bol\u00f3s","year":"2013","unstructured":"Bol\u00f3s V, Mira E, Mart\u00ednez-Poveda B, Lux\u00e1n G, Ca\u00f1amero M, Mart\u00ednez AC, et al. Notch activation stimulates migration of breast cancer cells and promotes tumor growth. Breast Cancer Res. 2013;15(4):R54. https:\/\/doi.org\/10.1186\/bcr3447.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"3080_CR61","doi-asserted-by":"publisher","first-page":"e2520724123","DOI":"10.1073\/pnas.2520724123","volume":"123","author":"O Cottrell","year":"2026","unstructured":"Cottrell O, Rowntree A, Chopra K, Mackellar E, Noble B, Dixon HL, et al. HES1 oscillations are required for cell cycle reentry in oestrogen receptor-positive breast cancer cells. Proc Natl Acad Sci U S A. 2026;123(10):e2520724123. https:\/\/doi.org\/10.1073\/pnas.2520724123.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"3080_CR62","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/2159-8290.Cd-17-0037","volume":"7","author":"Q Shen","year":"2017","unstructured":"Shen Q, Cohen B, Zheng W, Rahbar R, Martin B, Murakami K, et al. Notch Shapes the Innate Immunophenotype in Breast Cancer. Cancer Discov. 2017;7(11):1320\u201335. https:\/\/doi.org\/10.1158\/2159-8290.Cd-17-0037.","journal-title":"Cancer Discov"},{"issue":"1","key":"3080_CR63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12943-015-0295-3","volume":"14","author":"S Shao","year":"2015","unstructured":"Shao S, Zhao X, Zhang X, Luo M, Zuo X, Huang S, et al. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner. Mol Cancer. 2015;14(1):28. https:\/\/doi.org\/10.1186\/s12943-015-0295-3.","journal-title":"Mol Cancer"},{"issue":"6","key":"3080_CR64","first-page":"2681","volume":"8","author":"Y Liu","year":"2016","unstructured":"Liu Y, Su C, Shan Y, Yang S, Ma G. Targeting Notch1 inhibits invasion and angiogenesis of human breast cancer cells via inhibition Nuclear Factor-\u03baB signaling. Am J Transl Res. 2016;8(6):2681\u201392.","journal-title":"Am J Transl Res"},{"key":"3080_CR65","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3389\/fimmu.2019.00804","volume":"10","author":"Y Liubomirski","year":"2019","unstructured":"Liubomirski Y, Lerrer S, Meshel T, Morein D, Rubinstein-Achiasaf L, Sprinzak D, et al. Notch-Mediated Tumor-Stroma-Inflammation Networks Promote Invasive Properties and CXCL8 Expression in Triple-Negative Breast Cancer. Front Immunol. 2019;10:804. https:\/\/doi.org\/10.3389\/fimmu.2019.00804.","journal-title":"Front Immunol"},{"issue":"16","key":"3080_CR66","doi-asserted-by":"publisher","first-page":"4041","DOI":"10.7150\/thno.19989","volume":"7","author":"XW Dou","year":"2017","unstructured":"Dou XW, Liang YK, Lin HY, Wei XL, Zhang YQ, Bai JW, et al. Notch3 Maintains Luminal Phenotype and Suppresses Tumorigenesis and Metastasis of Breast Cancer via Trans-Activating Estrogen Receptor-\u03b1. Theranostics. 2017;7(16):4041\u201356. https:\/\/doi.org\/10.7150\/thno.19989.","journal-title":"Theranostics"},{"key":"3080_CR67","doi-asserted-by":"publisher","unstructured":"Ayaz F, Osborne BA. Non-Canonical Notch Signaling in Cancer and Immunity. Front Oncol. 2014;4\u20132014. https:\/\/doi.org\/10.3389\/fonc.2014.00345.","DOI":"10.3389\/fonc.2014.00345"},{"issue":"7","key":"3080_CR68","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1089\/scd.2015.0315","volume":"25","author":"V Bhat","year":"2016","unstructured":"Bhat V, Sun YJ, Weger S, Raouf A. Notch-Induced Expression of FZD7 Requires Noncanonical NOTCH3 Signaling in Human Breast Epithelial Cells. Stem Cells Dev. 2016;25(7):522\u20139. https:\/\/doi.org\/10.1089\/scd.2015.0315.","journal-title":"Stem Cells Dev"},{"issue":"41","key":"3080_CR69","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1038\/onc.2012.517","volume":"32","author":"S Jin","year":"2013","unstructured":"Jin S, Mutvei AP, Chivukula IV, Andersson ER, Ramsk\u00f6ld D, Sandberg R, et al. Non-canonical Notch signaling activates IL-6\/JAK\/STAT signaling in breast tumor cells and is controlled by p53 and IKK\u03b1\/IKK\u03b2. Oncogene. 2013;32(41):4892\u2013902. https:\/\/doi.org\/10.1038\/onc.2012.517.","journal-title":"Oncogene"},{"key":"3080_CR70","doi-asserted-by":"publisher","first-page":"370","DOI":"10.3389\/fphar.2019.00370","volume":"10","author":"L Liu","year":"2019","unstructured":"Liu L, Zhang L, Zhao S, Zhao XY, Min PX, Ma YD, et al. Non-canonical Notch Signaling Regulates Actin Remodeling in Cell Migration by Activating PI3K\/AKT\/Cdc42 Pathway. Front Pharmacol. 2019;10:370. https:\/\/doi.org\/10.3389\/fphar.2019.00370.","journal-title":"Front Pharmacol"},{"key":"3080_CR71","doi-asserted-by":"publisher","first-page":"575","DOI":"10.3389\/fonc.2018.00575","volume":"8","author":"F Hossain","year":"2018","unstructured":"Hossain F, Sorrentino C, Ucar DA, Peng Y, Matossian M, Wyczechowska D, et al. Notch Signaling Regulates Mitochondrial Metabolism and NF-\u03baB Activity in Triple-Negative Breast Cancer Cells via IKK\u03b1-Dependent Non-canonical Pathways. Front Oncol. 2018;8:575. https:\/\/doi.org\/10.3389\/fonc.2018.00575.","journal-title":"Front Oncol"},{"issue":"7","key":"3080_CR72","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/s41417-021-00411-8","volume":"29","author":"H Gonz\u00e1lez-King","year":"2022","unstructured":"Gonz\u00e1lez-King H, Tejedor S, Ciria M, Gil-Barrachina M, Soriano-Navarro M, S\u00e1nchez-S\u00e1nchez R, et al. Non-classical Notch signaling by MDA-MB-231 breast cancer cell-derived small extracellular vesicles promotes malignancy in poorly invasive MCF-7 cells. Cancer Gene Ther. 2022;29(7):1056\u201369. https:\/\/doi.org\/10.1038\/s41417-021-00411-8.","journal-title":"Cancer Gene Ther"},{"issue":"12","key":"3080_CR73","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.3390\/cancers12123765","volume":"12","author":"X Zhang","year":"2020","unstructured":"Zhang X, Powell K, Li L. Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond. Cancers. 2020;12(12):3765.","journal-title":"Cancers"},{"issue":"1","key":"3080_CR74","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.stemcr.2013.11.009","volume":"2","author":"S Liu","year":"2014","unstructured":"Liu S, Cong Y, Wang D, Sun Y, Deng L, Liu Y, et al. Breast cancer stem cells transition between epithelial and mesenchymal states reflective of their normal counterparts. Stem Cell Rep. 2014;2(1):78\u201391. https:\/\/doi.org\/10.1016\/j.stemcr.2013.11.009.","journal-title":"Stem Cell Rep"},{"issue":"10","key":"3080_CR75","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1002\/emmm.201302558","volume":"5","author":"DJ Azzam","year":"2013","unstructured":"Azzam DJ, Zhao D, Sun J, Minn AJ, Ranganathan P, Drews-Elger K, et al. Triple negative breast cancer initiating cell subsets differ in functional and molecular characteristics and in \u03b3-secretase inhibitor drug responses. EMBO Mol Med. 2013;5(10):1502\u201322. https:\/\/doi.org\/10.1002\/emmm.201302558.","journal-title":"EMBO Mol Med"},{"issue":"7","key":"3080_CR76","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1158\/1541-7786.Mcr-10-0457","volume":"9","author":"PM McGowan","year":"2011","unstructured":"McGowan PM, Simedrea C, Ribot EJ, Foster PJ, Palmieri D, Steeg PS, et al. Notch1 inhibition alters the CD44hi\/CD24lo population and reduces the formation of brain metastases from breast cancer. Mol Cancer Res. 2011;9(7):834\u201344. https:\/\/doi.org\/10.1158\/1541-7786.Mcr-10-0457.","journal-title":"Mol Cancer Res"},{"issue":"12","key":"3080_CR77","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1172\/jci76611","volume":"124","author":"D Zhao","year":"2014","unstructured":"Zhao D, Mo Y, Li MT, Zou SW, Cheng ZL, Sun YP, et al. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. J Clin Invest. 2014;124(12):5453\u201365. https:\/\/doi.org\/10.1172\/jci76611.","journal-title":"J Clin Invest"},{"key":"3080_CR78","doi-asserted-by":"publisher","first-page":"6865","DOI":"10.2147\/ott.S109606","volume":"9","author":"Y Zhong","year":"2016","unstructured":"Zhong Y, Shen S, Zhou Y, Mao F, Lin Y, Guan J, et al. NOTCH1 is a poor prognostic factor for breast cancer and is associated with breast cancer stem cells. Onco Targets Ther. 2016;9:6865\u201371. https:\/\/doi.org\/10.2147\/ott.S109606.","journal-title":"Onco Targets Ther"},{"key":"3080_CR79","doi-asserted-by":"publisher","first-page":"1150774","DOI":"10.3389\/fphar.2023.1150774","volume":"14","author":"U Saran","year":"2023","unstructured":"Saran U, Chandrasekaran B, Tyagi A, Shukla V, Singh A, Sharma AK, et al. A small molecule inhibitor of Notch1 modulates stemness and suppresses breast cancer cell growth. Front Pharmacol. 2023;14:1150774. https:\/\/doi.org\/10.3389\/fphar.2023.1150774.","journal-title":"Front Pharmacol"},{"issue":"2","key":"3080_CR80","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1158\/0008-5472.Can-09-1681","volume":"70","author":"H Harrison","year":"2010","unstructured":"Harrison H, Farnie G, Howell SJ, Rock RE, Stylianou S, Brennan KR, et al. Regulation of breast cancer stem cell activity by signaling through the Notch4 receptor. Cancer Res. 2010;70(2):709\u201318. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-1681.","journal-title":"Cancer Res"},{"issue":"3","key":"3080_CR81","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1158\/1535-7163.Mct-14-0228","volume":"14","author":"RC D\u2019Angelo","year":"2015","unstructured":"D\u2019Angelo RC, Ouzounova M, Davis A, Choi D, Tchuenkam SM, Kim G, et al. Notch reporter activity in breast cancer cell lines identifies a subset of cells with stem cell activity. Mol Cancer Ther. 2015;14(3):779\u201387. https:\/\/doi.org\/10.1158\/1535-7163.Mct-14-0228.","journal-title":"Mol Cancer Ther"},{"issue":"12","key":"3080_CR82","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1016\/j.celrep.2015.08.050","volume":"12","author":"BM Sim\u00f5es","year":"2015","unstructured":"Sim\u00f5es BM, O\u2019Brien CS, Eyre R, Silva A, Yu L, Sarmiento-Castro A, et al. Anti-estrogen Resistance in Human Breast Tumors Is Driven by JAG1-NOTCH4-Dependent Cancer Stem Cell Activity. Cell Rep. 2015;12(12):1968\u201377. https:\/\/doi.org\/10.1016\/j.celrep.2015.08.050.","journal-title":"Cell Rep"},{"key":"3080_CR83","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2018.04.023","volume":"428","author":"L Gelsomino","year":"2018","unstructured":"Gelsomino L, Panza S, Giordano C, Barone I, Gu G, Spina E, et al. Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines. Cancer Lett. 2018;428:12\u201320. https:\/\/doi.org\/10.1016\/j.canlet.2018.04.023.","journal-title":"Cancer Lett"},{"issue":"5","key":"3080_CR84","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.7150\/thno.38875","volume":"10","author":"L Zhou","year":"2020","unstructured":"Zhou L, Wang D, Sheng D, Xu J, Chen W, Qin Y, et al. NOTCH4 maintains quiescent mesenchymal-like breast cancer stem cells via transcriptionally activating SLUG and GAS1 in triple-negative breast cancer. Theranostics. 2020;10(5):2405\u201321. https:\/\/doi.org\/10.7150\/thno.38875.","journal-title":"Theranostics"},{"issue":"3","key":"3080_CR85","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1634\/stemcells.2006-0442","volume":"25","author":"P Sansone","year":"2007","unstructured":"Sansone P, Storci G, Giovannini C, Pandolfi S, Pianetti S, Taffurelli M, et al. p66Shc\/Notch-3 Interplay Controls Self-Renewal and Hypoxia Survival in Human Stem\/Progenitor Cells of the Mammary Gland Expanded In Vitro as Mammospheres. Stem Cells. 2007;25(3):807\u201315. https:\/\/doi.org\/10.1634\/stemcells.2006-0442.","journal-title":"Stem Cells"},{"key":"3080_CR86","doi-asserted-by":"publisher","first-page":"10442","DOI":"10.1038\/ncomms10442","volume":"7","author":"P Sansone","year":"2016","unstructured":"Sansone P, Ceccarelli C, Berishaj M, Chang Q, Rajasekhar VK, Perna F, et al. Self-renewal of CD133(hi) cells by IL6\/Notch3 signalling regulates endocrine resistance in metastatic breast cancer. Nat Commun. 2016;7:10442. https:\/\/doi.org\/10.1038\/ncomms10442.","journal-title":"Nat Commun"},{"issue":"4","key":"3080_CR87","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1158\/0008-5472.Can-08-2741","volume":"69","author":"E Charafe-Jauffret","year":"2009","unstructured":"Charafe-Jauffret E, Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res. 2009;69(4):1302\u201313. https:\/\/doi.org\/10.1158\/0008-5472.Can-08-2741.","journal-title":"Cancer Res"},{"issue":"2","key":"3080_CR88","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/s41416-019-0501-y","volume":"121","author":"M Capulli","year":"2019","unstructured":"Capulli M, Hristova D, Valbret Z, Carys K, Arjan R, Maurizi A, et al. Notch2 pathway mediates breast cancer cellular dormancy and mobilisation in bone and contributes to haematopoietic stem cell mimicry. Br J Cancer. 2019;121(2):157\u201371. https:\/\/doi.org\/10.1038\/s41416-019-0501-y.","journal-title":"Br J Cancer"},{"issue":"1","key":"3080_CR89","doi-asserted-by":"publisher","first-page":"3256","DOI":"10.1038\/s41467-020-16936-9","volume":"11","author":"K Miao","year":"2020","unstructured":"Miao K, Lei JH, Valecha MV, Zhang A, Xu J, Wang L, et al. NOTCH1 activation compensates BRCA1 deficiency and promotes triple-negative breast cancer formation. Nat Commun. 2020;11(1):3256. https:\/\/doi.org\/10.1038\/s41467-020-16936-9.","journal-title":"Nat Commun"},{"issue":"3","key":"3080_CR90","doi-asserted-by":"publisher","first-page":"R62","DOI":"10.1186\/bcr3675","volume":"16","author":"Y Lombardo","year":"2014","unstructured":"Lombardo Y, Faronato M, Filipovic A, Vircillo V, Magnani L, Coombes RC. Nicastrin and Notch4 drive endocrine therapy resistance and epithelial to mesenchymal transition in MCF7 breast cancer cells. Breast Cancer Res. 2014;16(3):R62. https:\/\/doi.org\/10.1186\/bcr3675.","journal-title":"Breast Cancer Res"},{"key":"3080_CR91","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.canlet.2017.01.014","volume":"390","author":"QT Bui","year":"2017","unstructured":"Bui QT, Im JH, Jeong SB, Kim YM, Lim SC, Kim B, et al. Essential role of Notch4\/STAT3 signaling in epithelial-mesenchymal transition of tamoxifen-resistant human breast cancer. Cancer Lett. 2017;390:115\u201325. https:\/\/doi.org\/10.1016\/j.canlet.2017.01.014.","journal-title":"Cancer Lett"},{"issue":"8","key":"3080_CR92","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41389-018-0069-z","volume":"7","author":"HY Lin","year":"2018","unstructured":"Lin HY, Liang YK, Dou XW, Chen CF, Wei XL, Zeng D, et al. Notch3 inhibits epithelial-mesenchymal transition in breast cancer via a novel mechanism, upregulation of GATA-3 expression. Oncogenesis. 2018;7(8):59. https:\/\/doi.org\/10.1038\/s41389-018-0069-z.","journal-title":"Oncogenesis"},{"key":"3080_CR93","doi-asserted-by":"publisher","unstructured":"Chen W, Zhang Y, Li R, Huang W, Wei X, Zeng D, et al. Notch3 Transactivates Glycogen Synthase Kinase-3-Beta and Inhibits Epithelial-to-Mesenchymal Transition in Breast Cancer Cells. Cells. 2022;11(18). https:\/\/doi.org\/10.3390\/cells11182872.","DOI":"10.3390\/cells11182872"},{"issue":"37","key":"3080_CR94","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.1038\/onc.2008.149","volume":"27","author":"C Osipo","year":"2008","unstructured":"Osipo C, Patel P, Rizzo P, Clementz AG, Hao L, Golde TE, et al. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor. Oncogene. 2008;27(37):5019\u201332. https:\/\/doi.org\/10.1038\/onc.2008.149.","journal-title":"Oncogene"},{"issue":"6","key":"3080_CR95","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1038\/bjc.2011.321","volume":"105","author":"K Pandya","year":"2011","unstructured":"Pandya K, Meeke K, Clementz AG, Rogowski A, Roberts J, Miele L, et al. Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Br J Cancer. 2011;105(6):796\u2013806. https:\/\/doi.org\/10.1038\/bjc.2011.321.","journal-title":"Br J Cancer"},{"issue":"33","key":"3080_CR96","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1038\/s41388-018-0251-y","volume":"37","author":"A Baker","year":"2018","unstructured":"Baker A, Wyatt D, Bocchetta M, Li J, Filipovic A, Green A, et al. Notch-1-PTEN-ERK1\/2 signaling axis promotes HER2\u2009+\u2009breast cancer cell proliferation and stem cell survival. Oncogene. 2018;37(33):4489\u2013504. https:\/\/doi.org\/10.1038\/s41388-018-0251-y.","journal-title":"Oncogene"},{"key":"3080_CR97","doi-asserted-by":"publisher","unstructured":"Xiao YS, Zeng D, Liang YK, Wu Y, Li MF, Qi YZ, et al. Major vault protein is a direct target of Notch1 signaling and contributes to chemoresistance in triple-negative breast cancer cells. Cancer Lett. 2019;440\u20131. https:\/\/doi.org\/10.1016\/j.canlet.2018.09.031.","DOI":"10.1016\/j.canlet.2018.09.031"},{"issue":"1","key":"3080_CR98","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41420-023-01487-x","volume":"9","author":"Y Qi","year":"2023","unstructured":"Qi Y, Li M, Li S, Zeng D, Xiao Y, Li J, et al. Notch1 promotes resistance to cisplatin by up-regulating Ecto-5\u2019-nucleotidase (CD73) in triple-negative breast cancer cells. Cell Death Discov. 2023;9(1):204. https:\/\/doi.org\/10.1038\/s41420-023-01487-x.","journal-title":"Cell Death Discov"},{"key":"3080_CR99","doi-asserted-by":"publisher","unstructured":"Lee YC, Wang WL, Chang WC, Huang YH, Hong GC, Wang HL, et al. Tribbles Homolog 3 Involved in Radiation Response of Triple Negative Breast Cancer Cells by Regulating Notch1 Activation. Cancers (Basel). 2019;11(2). https:\/\/doi.org\/10.3390\/cancers11020127.","DOI":"10.3390\/cancers11020127"},{"issue":"8","key":"3080_CR100","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1073\/pnas.1106509108","volume":"109","author":"JM Haughian","year":"2012","unstructured":"Haughian JM, Pinto MP, Harrell JC, Bliesner BS, Joensuu KM, Dye WW, et al. Maintenance of hormone responsiveness in luminal breast cancers by suppression of Notch. Proc Natl Acad Sci U S A. 2012;109(8):2742\u20137. https:\/\/doi.org\/10.1073\/pnas.1106509108.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3080_CR101","doi-asserted-by":"publisher","first-page":"e13754","DOI":"10.1111\/cpr.13754","volume":"58","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Qin X, Guo R, Sun X, Zhao Z, Guo H, et al. Notch-1 regulates collective breast cancer cell migration by controlling intercellular junction and cytoskeletal organization. Cell Prolif. 2025;58(2):e13754. https:\/\/doi.org\/10.1111\/cpr.13754.","journal-title":"Cell Prolif"},{"issue":"6","key":"3080_CR102","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41419-021-03735-3","volume":"12","author":"YQ Zhang","year":"2021","unstructured":"Zhang YQ, Liang YK, Wu Y, Chen M, Chen WL, Li RH, et al. Notch3 inhibits cell proliferation and tumorigenesis and predicts better prognosis in breast cancer through transactivating PTEN. Cell Death Dis. 2021;12(6):502. https:\/\/doi.org\/10.1038\/s41419-021-03735-3.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3080_CR103","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1186\/s12885-023-11746-w","volume":"23","author":"MN Chen","year":"2023","unstructured":"Chen MN, Fang ZX, Wu Z, Bai JW, Li RH, Wen XF, et al. Notch3 restricts metastasis of breast cancers through regulation of the JAK\/STAT5A signaling pathway. BMC Cancer. 2023;23(1):1257. https:\/\/doi.org\/10.1186\/s12885-023-11746-w.","journal-title":"BMC Cancer"},{"issue":"10","key":"3080_CR104","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1038\/s41419-020-03121-5","volume":"11","author":"Y Wu","year":"2020","unstructured":"Wu Y, Yuan MH, Wu HT, Chen WJ, Zhang ML, Ye QQ, et al. MicroRNA-488 inhibits proliferation and motility of tumor cells via downregulating FSCN1, modulated by Notch3 in breast carcinomas. Cell Death Dis. 2020;11(10):912. https:\/\/doi.org\/10.1038\/s41419-020-03121-5.","journal-title":"Cell Death Dis"},{"issue":"1","key":"3080_CR105","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s13058-018-1020-0","volume":"20","author":"AA Leontovich","year":"2018","unstructured":"Leontovich AA, Jalalirad M, Salisbury JL, Mills L, Haddox C, Schroeder M, et al. NOTCH3 expression is linked to breast cancer seeding and distant metastasis. Breast Cancer Res. 2018;20(1):105. https:\/\/doi.org\/10.1186\/s13058-018-1020-0.","journal-title":"Breast Cancer Res"},{"issue":"8","key":"3080_CR106","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1038\/oncsis.2013.26","volume":"2","author":"J Yun","year":"2013","unstructured":"Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, et al. Crosstalk between PKC\u03b1 and Notch-4 in endocrine-resistant breast cancer cells. Oncogenesis. 2013;2(8):e60. https:\/\/doi.org\/10.1038\/oncsis.2013.26.","journal-title":"Oncogenesis"},{"issue":"6","key":"3080_CR107","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1172\/jci74883","volume":"125","author":"DL Abravanel","year":"2015","unstructured":"Abravanel DL, Belka GK, Pan TC, Pant DK, Collins MA, Sterner CJ, et al. Notch promotes recurrence of dormant tumor cells following HER2\/neu-targeted therapy. J Clin Invest. 2015;125(6):2484\u201396. https:\/\/doi.org\/10.1172\/jci74883.","journal-title":"J Clin Invest"},{"issue":"1","key":"3080_CR108","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1186\/s12967-024-05536-6","volume":"22","author":"G Wang","year":"2024","unstructured":"Wang G, Wu Y, Su Y, Qu N, Chen B, Zhou D, et al. TCF12-regulated GRB7 facilitates the HER2\u2009+\u2009breast cancer progression by activating Notch1 signaling pathway. J Transl Med. 2024;22(1):745. https:\/\/doi.org\/10.1186\/s12967-024-05536-6.","journal-title":"J Transl Med"},{"issue":"18","key":"3080_CR109","doi-asserted-by":"publisher","first-page":"2599","DOI":"10.1038\/onc.2016.417","volume":"36","author":"X Xie","year":"2017","unstructured":"Xie X, Kaoud TS, Edupuganti R, Zhang T, Kogawa T, Zhao Y, et al. c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun. Oncogene. 2017;36(18):2599\u2013608. https:\/\/doi.org\/10.1038\/onc.2016.417.","journal-title":"Oncogene"},{"issue":"14","key":"3080_CR110","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1038\/s41388-017-0114-y","volume":"37","author":"GH Lee","year":"2018","unstructured":"Lee GH, Yoo KC, An Y, Lee HJ, Lee M, Uddin N, et al. FYN promotes mesenchymal phenotypes of basal type breast cancer cells through STAT5\/NOTCH2 signaling node. Oncogene. 2018;37(14):1857\u201368. https:\/\/doi.org\/10.1038\/s41388-017-0114-y.","journal-title":"Oncogene"},{"issue":"1","key":"3080_CR111","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10549-016-3795-y","volume":"157","author":"SH Kim","year":"2016","unstructured":"Kim SH, Hahm ER, Arlotti JA, Samanta SK, Moura MB, Thorne SH, et al. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown. Breast Cancer Res Treat. 2016;157(1):41\u201354. https:\/\/doi.org\/10.1007\/s10549-016-3795-y.","journal-title":"Breast Cancer Res Treat"},{"key":"3080_CR112","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41523-018-0073-7","volume":"4","author":"YK Liang","year":"2018","unstructured":"Liang YK, Lin HY, Dou XW, Chen M, Wei XL, Zhang YQ, et al. MiR-221\/222 promote epithelial-mesenchymal transition by targeting Notch3 in breast cancer cell lines. NPJ Breast Cancer. 2018;4:20. https:\/\/doi.org\/10.1038\/s41523-018-0073-7.","journal-title":"NPJ Breast Cancer"},{"issue":"1","key":"3080_CR113","doi-asserted-by":"publisher","first-page":"1729299","DOI":"10.1080\/2162402x.2020.1729299","volume":"9","author":"FA Mansour","year":"2020","unstructured":"Mansour FA, Al-Mazrou A, Al-Mohanna F, Al-Alwan M, Ghebeh H. PD-L1 is overexpressed on breast cancer stem cells through notch3\/mTOR axis. Oncoimmunology. 2020;9(1):1729299. https:\/\/doi.org\/10.1080\/2162402x.2020.1729299.","journal-title":"Oncoimmunology"},{"issue":"1","key":"3080_CR114","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41420-023-01450-w","volume":"9","author":"Y Tian","year":"2023","unstructured":"Tian Y, Zhang P, Mou Y, Yang W, Zhang J, Li Q, et al. Silencing Notch4 promotes tumorigenesis and inhibits metastasis of triple-negative breast cancer via Nanog and Cdc42. Cell Death Discov. 2023;9(1):148. https:\/\/doi.org\/10.1038\/s41420-023-01450-w.","journal-title":"Cell Death Discov"},{"key":"3080_CR115","doi-asserted-by":"publisher","unstructured":"Azadova A, Isayev O, Marco A, Brooke GN. The role of Notch signalling and its crosstalk with oestrogen receptor signalling in breast cancer. Cancer Metastasis Rev. 2026;45(2). https:\/\/doi.org\/10.1007\/s10555-026-10331-4.","DOI":"10.1007\/s10555-026-10331-4"},{"issue":"2","key":"3080_CR116","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/onc.2009.323","volume":"29","author":"L Hao","year":"2010","unstructured":"Hao L, Rizzo P, Osipo C, Pannuti A, Wyatt D, Cheung LW, et al. Notch-1 activates estrogen receptor-alpha-dependent transcription via IKKalpha in breast cancer cells. Oncogene. 2010;29(2):201\u201313. https:\/\/doi.org\/10.1038\/onc.2009.323.","journal-title":"Oncogene"},{"key":"3080_CR117","doi-asserted-by":"publisher","unstructured":"Chung WC, Egan SE, Xu K. A tumor-suppressive function for Notch3 in the parous mammary gland. Development. 2022;149(19). https:\/\/doi.org\/10.1242\/dev.200913.","DOI":"10.1242\/dev.200913"},{"issue":"19","key":"3080_CR118","doi-asserted-by":"publisher","first-page":"5963","DOI":"10.1158\/0008-5472.Can-13-0409","volume":"73","author":"H Ling","year":"2013","unstructured":"Ling H, Sylvestre JR, Jolicoeur P. Cyclin D1-dependent induction of luminal inflammatory breast tumors by activated notch3. Cancer Res. 2013;73(19):5963\u201373. https:\/\/doi.org\/10.1158\/0008-5472.Can-13-0409.","journal-title":"Cancer Res"},{"issue":"1","key":"3080_CR119","doi-asserted-by":"publisher","first-page":"78","DOI":"10.4103\/1735-5362.363598","volume":"18","author":"A Boustan","year":"2023","unstructured":"Boustan A, Jahangiri R, Ghalehno AD, Khorsandi M, Mosaffa F, Jamialahmadi K. Expression analysis elucidates the roles of Nicastrin, Notch4, and Hes1 in prognosis and endocrine-therapy resistance in ER-positive breast cancer patients. Res Pharm Sci. 2023;18(1):78\u201388. https:\/\/doi.org\/10.4103\/1735-5362.363598.","journal-title":"Res Pharm Sci"},{"issue":"3","key":"3080_CR120","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.1365-2559.2009.03475.x","volume":"56","author":"SJ Zardawi","year":"2010","unstructured":"Zardawi SJ, Zardawi I, McNeil CM, Millar EK, McLeod D, Morey AL, et al. High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype. Histopathology. 2010;56(3):286\u201396. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03475.x.","journal-title":"Histopathology"},{"issue":"6","key":"3080_CR121","doi-asserted-by":"publisher","first-page":"8749","DOI":"10.3892\/ol.2018.8442","volume":"15","author":"JW Wang","year":"2018","unstructured":"Wang JW, Wei XL, Dou XW, Huang WH, Du CW, Zhang GJ. The association between Notch4 expression, and clinicopathological characteristics and clinical outcomes in patients with breast cancer. Oncol Lett. 2018;15(6):8749\u201355. https:\/\/doi.org\/10.3892\/ol.2018.8442.","journal-title":"Oncol Lett"},{"issue":"12","key":"3080_CR122","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1038\/s44321-024-00161-8","volume":"16","author":"M Fournier","year":"2024","unstructured":"Fournier M, Javary J, Roh V, Fournier N, Radtke F. Reciprocal inhibition of NOTCH and SOX2 shapes tumor cell plasticity and therapeutic escape in triple-negative breast cancer. EMBO Mol Med. 2024;16(12):3184\u2013217. https:\/\/doi.org\/10.1038\/s44321-024-00161-8.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3080_CR123","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/bd-220041","volume":"42","author":"H Shah","year":"2023","unstructured":"Shah H, Mistry M, Patel N, Vora H. Clinical significance of Notch receptors in triple negative breast cancer. Breast Dis. 2023;42(1):85\u2013100. https:\/\/doi.org\/10.3233\/bd-220041.","journal-title":"Breast Dis"},{"issue":"6","key":"3080_CR124","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1158\/0008-5472.Can-16-1022","volume":"77","author":"L Choy","year":"2017","unstructured":"Choy L, Hagenbeek TJ, Solon M, French D, Finkle D, Shelton A, et al. Constitutive NOTCH3 Signaling Promotes the Growth of Basal Breast Cancers. Cancer Res. 2017;77(6):1439\u201352. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-1022.","journal-title":"Cancer Res"},{"key":"3080_CR125","doi-asserted-by":"publisher","first-page":"594372","DOI":"10.3389\/fcell.2020.594372","volume":"8","author":"W Xiong","year":"2020","unstructured":"Xiong W, Tan J, Guo Y, Chen S, Fan L, Li Y. Notch3 Knockout Suppresses Mouse Mammary Gland Development and Inhibits the Proliferation of 4T1 Murine Mammary Carcinoma Cells via CCL2\/CCR4 Axis. Front Cell Dev Biol. 2020;8:594372. https:\/\/doi.org\/10.3389\/fcell.2020.594372.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"3080_CR126","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.17305\/bb.2026.13708","volume":"26","author":"R Li","year":"2026","unstructured":"Li R, Wang Y, Xie M. Tumor microenvironment and key signaling pathways in breast cancer progression and therapy resistance: A review. Biomol Biomed. 2026;26(9):1461\u201375. https:\/\/doi.org\/10.17305\/bb.2026.13708.","journal-title":"Biomol Biomed"},{"issue":"9","key":"3080_CR127","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1.","journal-title":"Nat Genet"},{"key":"3080_CR128","doi-asserted-by":"publisher","first-page":"154928","DOI":"10.1016\/j.phymed.2023.154928","volume":"123","author":"H Chen","year":"2024","unstructured":"Chen H, Han X, Zhang Y, Wang K, Liu D, Hu Z, et al. Bruceine D suppresses CAF-promoted TNBC metastasis under TNF-\u03b1 stimulation by inhibiting Notch1-Jagged1\/NF-\u03baB(p65) signaling. Phytomedicine. 2024;123:154928. https:\/\/doi.org\/10.1016\/j.phymed.2023.154928.","journal-title":"Phytomedicine"},{"key":"3080_CR129","doi-asserted-by":"publisher","first-page":"177994","DOI":"10.1016\/j.ejphar.2025.177994","volume":"1003","author":"J Ma","year":"2025","unstructured":"Ma J, Cao D, Zhang Y, Sun Y, Wu Y, Wang J. Bruceine D inhibits CAF-promoted angiogenesis of breast cancer via suppressing IL-6-mediated activation of the STAT3\/Notch1\/VEGFR2 axis. Eur J Pharmacol. 2025;1003:177994. https:\/\/doi.org\/10.1016\/j.ejphar.2025.177994.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"3080_CR130","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1186\/s12967-025-06794-8","volume":"23","author":"L Yang","year":"2025","unstructured":"Yang L, Zhao S, Liu X, Zhang Y, Zhao S, Fang X, et al. Hypoxic cancer-associated fibroblast exosomal circSTAT3 drives triple negative breast cancer stemness via miR-671-5p\/NOTCH1 signaling. J Transl Med. 2025;23(1):814. https:\/\/doi.org\/10.1186\/s12967-025-06794-8.","journal-title":"J Transl Med"},{"issue":"20","key":"3080_CR131","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.1158\/0008-5472.Can-21-1225","volume":"82","author":"A Nandi","year":"2022","unstructured":"Nandi A, Debnath R, Nayak A, To TKJ, Thacker G, Reilly M, et al. Dll1-Mediated Notch Signaling Drives Tumor Cell Cross-talk with Cancer-Associated Fibroblasts to Promote Radioresistance in Breast Cancer. Cancer Res. 2022;82(20):3718\u201333. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-1225.","journal-title":"Cancer Res"},{"key":"3080_CR132","doi-asserted-by":"publisher","first-page":"114800","DOI":"10.1016\/j.biopha.2023.114800","volume":"163","author":"B Lawal","year":"2023","unstructured":"Lawal B, Wu AT, Chen CH, Wu TAG. Identification of INFG\/STAT1\/NOTCH3 as \u03b3-Mangostin\u2019s potential targets for overcoming doxorubicin resistance and reducing cancer-associated fibroblasts in triple-negative breast cancer. Biomed Pharmacother. 2023;163:114800. https:\/\/doi.org\/10.1016\/j.biopha.2023.114800.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"3080_CR133","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.cell.2009.03.025","volume":"137","author":"R Benedito","year":"2009","unstructured":"Benedito R, Roca C, S\u00f6rensen I, Adams S, Gossler A, Fruttiger M, et al. The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis. Cell. 2009;137(6):1124\u201335. https:\/\/doi.org\/10.1016\/j.cell.2009.03.025.","journal-title":"Cell"},{"issue":"4","key":"3080_CR134","doi-asserted-by":"publisher","first-page":"562","DOI":"10.4048\/jbc.2019.22.e56","volume":"22","author":"D Kim","year":"2019","unstructured":"Kim D, Lee J, Kang J, Kim SH, Yoo TK, Oh S, et al. Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer. J Breast Cancer. 2019;22(4):562\u201378. https:\/\/doi.org\/10.4048\/jbc.2019.22.e56.","journal-title":"J Breast Cancer"},{"issue":"1","key":"3080_CR135","doi-asserted-by":"publisher","first-page":"16074","DOI":"10.1038\/ncomms16074","volume":"8","author":"S Lin","year":"2017","unstructured":"Lin S, Negulescu A, Bulusu S, Gibert B, Delcros J-G, Ducarouge B, et al. Non-canonical NOTCH3 signalling limits tumour angiogenesis. Nat Commun. 2017;8(1):16074. https:\/\/doi.org\/10.1038\/ncomms16074.","journal-title":"Nat Commun"},{"issue":"2","key":"3080_CR136","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1177\/1066896911427035","volume":"20","author":"J Speiser","year":"2012","unstructured":"Speiser J, Foreman K, Drinka E, Godellas C, Perez C, Salhadar A, et al. Notch-1 and Notch-4 biomarker expression in triple-negative breast cancer. Int J Surg Pathol. 2012;20(2):139\u201345. https:\/\/doi.org\/10.1177\/1066896911427035.","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"3080_CR137","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2045-824X-5-7","volume":"5","author":"MJ Costa","year":"2013","unstructured":"Costa MJ, Wu X, Cuervo H, Srinivasan R, Bechis SK, Cheang E, et al. Notch4 is required for tumor onset and perfusion. Vascular Cell. 2013;5(1):7. https:\/\/doi.org\/10.1186\/2045-824X-5-7.","journal-title":"Vascular Cell"},{"issue":"7","key":"3080_CR138","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1158\/2767-9764.Crc-24-0081","volume":"4","author":"JW Eng","year":"2024","unstructured":"Eng JW, Kato Y, Adachi Y, Swaminathan B, Naiche LA, Vadakath R, et al. Inhibition of Notch4 Using Novel Neutralizing Antibodies Reduces Tumor Growth in Murine Cancer Models by Targeting the Tumor Endothelium. Cancer Res Commun. 2024;4(7):1881\u201393. https:\/\/doi.org\/10.1158\/2767-9764.Crc-24-0081.","journal-title":"Cancer Res Commun"},{"issue":"1","key":"3080_CR139","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13058-025-02045-2","volume":"27","author":"Y Gao","year":"2025","unstructured":"Gao Y, Zuo L, Zheng Y, Sun K, Gao Y, Xu X, et al. NOTCH1 inhibition enhances immunogenicity and sensitizes triple-negative breast cancer to immune checkpoint inhibitors. Breast Cancer Res. 2025;27(1):92. https:\/\/doi.org\/10.1186\/s13058-025-02045-2.","journal-title":"Breast Cancer Res"},{"issue":"44","key":"3080_CR140","doi-asserted-by":"publisher","first-page":"eado8275","DOI":"10.1126\/sciadv.ado8275","volume":"10","author":"Q Shen","year":"2024","unstructured":"Shen Q, Murakami K, Sotov V, Butler M, Ohashi PS, Reedijk M. Inhibition of Notch enhances efficacy of immune checkpoint blockade in triple-negative breast cancer. Sci Adv. 2024;10(44):eado8275. https:\/\/doi.org\/10.1126\/sciadv.ado8275.","journal-title":"Sci Adv"},{"issue":"6","key":"3080_CR141","doi-asserted-by":"publisher","first-page":"361","DOI":"10.21037\/atm-22-1041","volume":"10","author":"S Ren","year":"2022","unstructured":"Ren S, Hu Y, Ju Y, Sang Y, Wu J, Ge Y, et al. Blocking the Notch signal transduction pathway promotes tumor growth in breast cancer by promoting the expression of suppressible inflammatory factors. Ann Transl Med. 2022;10(6):361. https:\/\/doi.org\/10.21037\/atm-22-1041.","journal-title":"Ann Transl Med"},{"issue":"4","key":"3080_CR142","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.5114\/aoms\/187080","volume":"21","author":"H Li","year":"2025","unstructured":"Li H, Fan J, Ma J, Qiao L, Sha T, Ma B. Exosomal miR-182-5p from breast cancer cells reprogram tumor-associated macrophages and promote triple-negative breast cancer progression by targeting Notch1 in macrophages. Arch Med Sci. 2025;21(4):1471\u201386. https:\/\/doi.org\/10.5114\/aoms\/187080.","journal-title":"Arch Med Sci"},{"issue":"5","key":"3080_CR143","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1007\/s10637-020-00895-5","volume":"38","author":"S Sardesai","year":"2020","unstructured":"Sardesai S, Badawi M, Mrozek E, Morgan E, Phelps M, Stephens J, et al. A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Invest New Drugs. 2020;38(5):1400\u201310. https:\/\/doi.org\/10.1007\/s10637-020-00895-5.","journal-title":"Invest New Drugs"},{"issue":"2","key":"3080_CR144","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.clbc.2021.10.013","volume":"22","author":"JA Means-Powell","year":"2022","unstructured":"Means-Powell JA, Mayer IA, Ismail-Khan R, Del Valle L, Tonetti D, Abramson VG, et al. A Phase Ib Dose Escalation Trial of RO4929097 (a \u03b3-secretase inhibitor) in Combination with Exemestane in Patients with ER\u2009+\u2009Metastatic Breast Cancer (MBC). Clin Breast Cancer. 2022;22(2):103\u201314. https:\/\/doi.org\/10.1016\/j.clbc.2021.10.013.","journal-title":"Clin Breast Cancer"},{"issue":"6","key":"3080_CR145","doi-asserted-by":"publisher","first-page":"1512","DOI":"10.1158\/1078-0432.Ccr-11-3326","volume":"19","author":"AF Schott","year":"2013","unstructured":"Schott AF, Landis MD, Dontu G, Griffith KA, Layman RM, Krop I, et al. Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors. Clin Cancer Res. 2013;19(6):1512\u201324. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-3326.","journal-title":"Clin Cancer Res"},{"issue":"24Supplement","key":"3080_CR146","first-page":"PD05","volume":"70","author":"K Albain","year":"2010","unstructured":"Albain K, Czerlanis C, Rajan P, Zlobin A, Godellas C, Bova D, et al. Abstract PD05-12: Combination of Notch Inhibitor MK-0752 and Endocrine Therapy for Early Stage ER\u03b1\u2009+\u2009Breast Cancer in a Presurgical Window Pilot Study. Cancer Res. 2010;70(24Supplement):PD05\u201312. -PD05-12.","journal-title":"Cancer Res"},{"issue":"2","key":"3080_CR147","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.18632\/oncotarget.13727","volume":"8","author":"MA Locatelli","year":"2017","unstructured":"Locatelli MA, Aftimos P, Dees EC, LoRusso PM, Pegram MD, Awada A, et al. Phase I study of the gamma secretase inhibitor PF-03084014 in combination with docetaxel in patients with advanced triple-negative breast cancer. Oncotarget. 2017;8(2):2320\u20138. https:\/\/doi.org\/10.18632\/oncotarget.13727.","journal-title":"Oncotarget"},{"issue":"4","key":"3080_CR148","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1007\/s10637-021-01094-6","volume":"39","author":"A Azaro","year":"2021","unstructured":"Azaro A, Massard C, Tap WD, Cassier PA, Merchan J, Italiano A, et al. A phase 1b study of the Notch inhibitor crenigacestat (LY3039478) in combination with other anticancer target agents (taladegib, LY3023414, or abemaciclib) in patients with advanced or metastatic solid tumors. Invest New Drugs. 2021;39(4):1089\u201398. https:\/\/doi.org\/10.1007\/s10637-021-01094-6.","journal-title":"Invest New Drugs"},{"issue":"4","key":"3080_CR149","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00280-022-04461-z","volume":"90","author":"C Massard","year":"2022","unstructured":"Massard C, Cassier PA, Azaro A, Anderson B, Yuen E, Yu D, et al. A phase 1b study of crenigacestat (LY3039478) in combination with gemcitabine and cisplatin or gemcitabine and carboplatin in patients with advanced or metastatic solid tumors. Cancer Chemother Pharmacol. 2022;90(4):335\u201344. https:\/\/doi.org\/10.1007\/s00280-022-04461-z.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3080_CR150","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s10637-019-00754-y","volume":"38","author":"LS Rosen","year":"2020","unstructured":"Rosen LS, Wesolowski R, Baffa R, Liao KH, Hua SY, Gibson BL, et al. A phase I, dose-escalation study of PF-06650808, an anti-Notch3 antibody-drug conjugate, in patients with breast cancer and other advanced solid tumors. Invest New Drugs. 2020;38(1):120\u201330. https:\/\/doi.org\/10.1007\/s10637-019-00754-y.","journal-title":"Invest New Drugs"},{"key":"3080_CR151","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fncel.2014.00427","volume":"8","author":"X Zhang","year":"2014","unstructured":"Zhang X, Li Y, Xu H, Zhang YW. The \u03b3-secretase complex: from structure to function. Front Cell Neurosci. 2014;8:427. https:\/\/doi.org\/10.3389\/fncel.2014.00427.","journal-title":"Front Cell Neurosci"},{"issue":"12","key":"3080_CR152","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1016\/j.bbamem.2013.06.005","volume":"1828","author":"TE Golde","year":"2013","unstructured":"Golde TE, Koo EH, Felsenstein KM, Osborne BA, Miele L. \u03b3-Secretase inhibitors and modulators. Biochim Biophys Acta. 2013;1828(12):2898\u2013907. https:\/\/doi.org\/10.1016\/j.bbamem.2013.06.005.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"3080_CR153","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1021\/acsptsci.3c00099","volume":"6","author":"P Sen","year":"2023","unstructured":"Sen P, Ghosh SS. \u03b3-Secretase Inhibitor Potentiates the Activity of Suberoylanilide Hydroxamic Acid by Inhibiting Its Ability to Induce Epithelial to Mesenchymal Transition and Stemness via Notch Pathway Activation in Triple-Negative Breast Cancer Cells. ACS Pharmacol Transl Sci. 2023;6(10):1396\u2013415. https:\/\/doi.org\/10.1021\/acsptsci.3c00099.","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"1","key":"3080_CR154","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1021\/acsami.4c16278","volume":"17","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhou Y, Li Y, Kang W, Zhang Y, Xia X, et al. Notch Pathway Deactivation Sensitizes Breast Cancer Stem Cells toward Chemotherapy Using NIR Light-Responsive Nanoparticles. ACS Appl Mater Interfaces. 2025;17(1):430\u201344. https:\/\/doi.org\/10.1021\/acsami.4c16278.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"5","key":"3080_CR155","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/mt.2016.42","volume":"24","author":"V Mamaeva","year":"2016","unstructured":"Mamaeva V, Niemi R, Beck M, \u00d6zliseli E, Desai D, Landor S, et al. Inhibiting Notch Activity in Breast Cancer Stem Cells by Glucose Functionalized Nanoparticles Carrying \u03b3-secretase Inhibitors. Mol Ther. 2016;24(5):926\u201336. https:\/\/doi.org\/10.1038\/mt.2016.42.","journal-title":"Mol Ther"},{"key":"3080_CR156","doi-asserted-by":"publisher","first-page":"105033","DOI":"10.1016\/j.chemphyslip.2020.105033","volume":"235","author":"S Pindiprolu","year":"2021","unstructured":"Pindiprolu S, Krishnamurthy PT, Dev C, Chintamaneni PK. DR5 antibody conjugated lipid-based nanocarriers of gamma-secretase inhibitor for the treatment of triple negative breast cancer. Chem Phys Lipids. 2021;235:105033. https:\/\/doi.org\/10.1016\/j.chemphyslip.2020.105033.","journal-title":"Chem Phys Lipids"},{"issue":"4","key":"3080_CR157","doi-asserted-by":"publisher","first-page":"618","DOI":"10.34172\/apb.2021.070","volume":"11","author":"M Kumari","year":"2021","unstructured":"Kumari M, Krishnamurthy PT, Pinduprolu S, Sola P. DR-5 and DLL-4 mAb Functionalized SLNs of Gamma-Secretase Inhibitors- An Approach for TNBC Treatment. Adv Pharm Bull. 2021;11(4):618\u201323. https:\/\/doi.org\/10.34172\/apb.2021.070.","journal-title":"Adv Pharm Bull"},{"key":"3080_CR158","doi-asserted-by":"publisher","first-page":"125142","DOI":"10.1016\/j.ijpharm.2024.125142","volume":"670","author":"M Kumari","year":"2025","unstructured":"Kumari M, Piyongsola, Ravi Naik M, Singh Rathore H, Kumar Shukla A, Iqbal Dar A, et al. Targeted delivery of DAPT using dual antibody functionalized solid lipid nanoparticles for enhanced anti-tumour activity against triple negative breast cancer. Int J Pharm. 2025;670:125142. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125142.","journal-title":"Int J Pharm"},{"key":"3080_CR159","doi-asserted-by":"publisher","first-page":"1244159","DOI":"10.3389\/fimmu.2023.1244159","volume":"14","author":"F Hossain","year":"2023","unstructured":"Hossain F, Ucar DA, Monticone G, Ran Y, Majumder S, Larter K, et al. Sulindac sulfide as a non-immune suppressive \u03b3-secretase modulator to target triple-negative breast cancer. Front Immunol. 2023;14:1244159. https:\/\/doi.org\/10.3389\/fimmu.2023.1244159.","journal-title":"Front Immunol"},{"key":"3080_CR160","doi-asserted-by":"publisher","first-page":"125037","DOI":"10.1016\/j.ijpharm.2024.125037","volume":"669","author":"M Entezam","year":"2025","unstructured":"Entezam M, Bagheri N, Soltani A, Hosseini SA, Khosravian P, Ferns GA, et al. Enhanced antitumor immunity in breast cancer: Synergistic effects of ADAM10\/ADAM17 inhibition, metabolic modulation, and camptothecin-loaded selenium nanoparticles. Int J Pharm. 2025;669:125037. https:\/\/doi.org\/10.1016\/j.ijpharm.2024.125037.","journal-title":"Int J Pharm"},{"key":"3080_CR161","doi-asserted-by":"publisher","first-page":"110529","DOI":"10.1016\/j.cellsig.2022.110529","volume":"102","author":"P Sen","year":"2023","unstructured":"Sen P, Kandasamy T, Ghosh SS. Multi-targeting TACE\/ADAM17 and gamma-secretase of notch signalling pathway in TNBC via drug repurposing approach using Lomitapide. Cell Signal. 2023;102:110529. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110529.","journal-title":"Cell Signal"},{"issue":"29","key":"3080_CR162","doi-asserted-by":"publisher","first-page":"7842","DOI":"10.1039\/d3sc01071f","volume":"14","author":"AM Mallick","year":"2023","unstructured":"Mallick AM, Biswas A, Mishra S, Jadhav S, Chakraborty K, Tripathi A, et al. Engineered vitamin E-tethered non-immunogenic facial lipopeptide for developing improved siRNA based combination therapy against metastatic breast cancer. Chem Sci. 2023;14(29):7842\u201366. https:\/\/doi.org\/10.1039\/d3sc01071f.","journal-title":"Chem Sci"},{"key":"3080_CR163","doi-asserted-by":"publisher","first-page":"138418","DOI":"10.1016\/j.ijbiomac.2024.138418","volume":"287","author":"H Dadashi","year":"2025","unstructured":"Dadashi H, Mashinchian M, Karimian-Shaddel A, Mohabbat A, Vandghanooni S, Eskandani M, et al. Chitosan nanoparticles loaded with metformin and digoxin synergistically inhibit MCF-7 breast cancer cells through suppression of NOTCH-1 and HIF-1\u03b1 gene expression. Int J Biol Macromol. 2025;287:138418. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.138418.","journal-title":"Int J Biol Macromol"},{"key":"3080_CR164","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.omtn.2020.06.003","volume":"21","author":"DM Valcourt","year":"2020","unstructured":"Valcourt DM, Day ES. Dual Regulation of miR-34a and Notch Signaling in Triple-Negative Breast Cancer by Antibody\/miRNA Nanocarriers. Mol Ther Nucleic Acids. 2020;21:290\u20138. https:\/\/doi.org\/10.1016\/j.omtn.2020.06.003.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"3","key":"3080_CR165","doi-asserted-by":"publisher","first-page":"3378","DOI":"10.1021\/acsnano.9b09263","volume":"14","author":"DM Valcourt","year":"2020","unstructured":"Valcourt DM, Dang MN, Scully MA, Day ES. Nanoparticle-Mediated Co-Delivery of Notch-1 Antibodies and ABT-737 as a Potent Treatment Strategy for Triple-Negative Breast Cancer. ACS Nano. 2020;14(3):3378\u201388. https:\/\/doi.org\/10.1021\/acsnano.9b09263.","journal-title":"ACS Nano"},{"issue":"3","key":"3080_CR166","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s00210-020-01988-x","volume":"394","author":"F Nasser","year":"2021","unstructured":"Nasser F, Moussa N, Helmy MW, Haroun M. Dual targeting of Notch and Wnt\/\u03b2-catenin pathways: Potential approach in triple-negative breast cancer treatment. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(3):481\u201390. https:\/\/doi.org\/10.1007\/s00210-020-01988-x.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"3080_CR167","doi-asserted-by":"publisher","unstructured":"Wawruszak A, Luszczki J, Halasa M, Okon E, Landor S, Sahlgren C, et al. Sensitization of MCF7 Cells with High Notch1 Activity by Cisplatin and Histone Deacetylase Inhibitors Applied Together. Int J Mol Sci. 2021;22(10). https:\/\/doi.org\/10.3390\/ijms22105184.","DOI":"10.3390\/ijms22105184"},{"issue":"1","key":"3080_CR168","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s13058-021-01488-7","volume":"23","author":"M Zhang","year":"2021","unstructured":"Zhang M, Meng M, Liu Y, Qi J, Zhao Z, Qiao Y, et al. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. Breast Cancer Res. 2021;23(1):116. https:\/\/doi.org\/10.1186\/s13058-021-01488-7.","journal-title":"Breast Cancer Res"},{"key":"3080_CR169","doi-asserted-by":"publisher","first-page":"116133","DOI":"10.1016\/j.jep.2023.116133","volume":"305","author":"Y Liao","year":"2023","unstructured":"Liao Y, Luo Z, Liu Y, Xue W, He S, Chen X, et al. Total flavonoids of Litchi seed attenuate stem cell-like properties in breast cancer by regulating Notch3 signaling pathway. J Ethnopharmacol. 2023;305:116133. https:\/\/doi.org\/10.1016\/j.jep.2023.116133.","journal-title":"J Ethnopharmacol"},{"issue":"7270","key":"3080_CR170","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature08543","volume":"462","author":"RE Moellering","year":"2009","unstructured":"Moellering RE, Cornejo M, Davis TN, Del Bianco C, Aster JC, Blacklow SC, et al. Direct inhibition of the NOTCH transcription factor complex. Nature. 2009;462(7270):182\u20138. https:\/\/doi.org\/10.1038\/nature08543.","journal-title":"Nature"},{"issue":"12","key":"3080_CR171","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1158\/0008-5472.Can-16-0061","volume":"76","author":"L Astudillo","year":"2016","unstructured":"Astudillo L, Da Silva TG, Wang Z, Han X, Jin K, VanWye J, et al. The Small Molecule IMR-1 Inhibits the Notch Transcriptional Activation Complex to Suppress Tumorigenesis. Cancer Res. 2016;76(12):3593\u2013603. https:\/\/doi.org\/10.1158\/0008-5472.Can-16-0061.","journal-title":"Cancer Res"},{"issue":"28","key":"3080_CR172","doi-asserted-by":"publisher","first-page":"16292","DOI":"10.1073\/pnas.1922606117","volume":"117","author":"R Lehal","year":"2020","unstructured":"Lehal R, Zaric J, Vigolo M, Urech C, Frismantas V, Zangger N, et al. Pharmacological disruption of the Notch transcription factor complex. Proc Natl Acad Sci U S A. 2020;117(28):16292\u2013301. https:\/\/doi.org\/10.1073\/pnas.1922606117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3080_CR173","doi-asserted-by":"publisher","unstructured":"Vigolo M, Urech C, Lamy S, Monticone G, Zabaleta J, Hossain F, et al. The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer. Cancers (Basel). 2023;15(15). https:\/\/doi.org\/10.3390\/cancers15153957.","DOI":"10.3390\/cancers15153957"},{"issue":"9","key":"3080_CR174","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1158\/2767-9764.Crc-23-0333","volume":"3","author":"GJ Hanna","year":"2023","unstructured":"Hanna GJ, Stathis A, Lopez-Miranda E, Racca F, Quon D, Leyvraz S, et al. A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors. Cancer Res Commun. 2023;3(9):1853\u201361. https:\/\/doi.org\/10.1158\/2767-9764.Crc-23-0333.","journal-title":"Cancer Res Commun"},{"issue":"2","key":"3080_CR175","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1158\/2159-8290.Cd-14-0650","volume":"5","author":"T Kangsamaksin","year":"2015","unstructured":"Kangsamaksin T, Murtomaki A, Kofler NM, Cuervo H, Chaudhri RA, Tattersall IW, et al. NOTCH decoys that selectively block DLL\/NOTCH or JAG\/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth. Cancer Discov. 2015;5(2):182\u201397. https:\/\/doi.org\/10.1158\/2159-8290.Cd-14-0650.","journal-title":"Cancer Discov"},{"issue":"2","key":"3080_CR176","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s10456-022-09861-6","volume":"26","author":"T Sargis","year":"2023","unstructured":"Sargis T, Youn SW, Thakkar K, Naiche LA, Paik NY, Pajcini KV, et al. Notch1 and Notch4 core binding domain peptibodies exhibit distinct ligand-binding and anti-angiogenic properties. Angiogenesis. 2023;26(2):249\u201363. https:\/\/doi.org\/10.1007\/s10456-022-09861-6.","journal-title":"Angiogenesis"},{"issue":"6781","key":"3080_CR177","doi-asserted-by":"publisher","first-page":"eads9530","DOI":"10.1126\/science.ads9530","volume":"391","author":"Y Jia","year":"2026","unstructured":"Jia Y, Gao B, Tan J, Zheng J, Hong X, Zhu W, et al. Deep contrastive learning enables genome-wide virtual screening. Science. 2026;391(6781):eads9530. https:\/\/doi.org\/10.1126\/science.ads9530.","journal-title":"Science"},{"issue":"1","key":"3080_CR178","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1007\/s12672-025-03764-w","volume":"16","author":"TT Laskar","year":"2025","unstructured":"Laskar TT, Laskar HM, Mazumder JA, Bhattacharjee R, Husain MI, Das B, et al. Decoding breast cancer: insights into molecular pathways & therapeutic approaches. Discov Oncol. 2025;16(1):2103. https:\/\/doi.org\/10.1007\/s12672-025-03764-w.","journal-title":"Discov Oncol"},{"key":"3080_CR179","doi-asserted-by":"publisher","first-page":"9723304","DOI":"10.1155\/bmri\/9723304","volume":"2026","author":"P Teimoori","year":"2026","unstructured":"Teimoori P, Khatir K, Heidari M. Designing a Multi-Epitope Vaccine Against NOTCH1 and NOTCH4: A Computational Approach for Triple-Negative Breast Cancer. Biomed Res Int. 2026;2026:9723304. https:\/\/doi.org\/10.1155\/bmri\/9723304.","journal-title":"Biomed Res Int"},{"issue":"1","key":"3080_CR180","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1186\/s12967-023-04713-3","volume":"21","author":"M Omar","year":"2023","unstructured":"Omar M, Nuzzo PV, Ravera F, Bleve S, Fanelli GN, Zanettini C, et al. Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. J Transl Med. 2023;21(1):811. https:\/\/doi.org\/10.1186\/s12967-023-04713-3.","journal-title":"J Transl Med"},{"key":"3080_CR181","doi-asserted-by":"publisher","first-page":"114938","DOI":"10.1016\/j.biopha.2023.114938","volume":"164","author":"P Pandey","year":"2023","unstructured":"Pandey P, Khan F, Choi M, Singh SK, Kang HN, Park MN, et al. Review deciphering potent therapeutic approaches targeting Notch signaling pathway in breast cancer. Biomed Pharmacother. 2023;164:114938. https:\/\/doi.org\/10.1016\/j.biopha.2023.114938.","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"3080_CR182","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.stem.2008.08.001","volume":"3","author":"T Bouras","year":"2008","unstructured":"Bouras T, Pal B, Vaillant F, Harburg G, Asselin-Labat ML, Oakes SR, et al. Notch signaling regulates mammary stem cell function and luminal cell-fate commitment. Cell Stem Cell. 2008;3(4):429\u201341. https:\/\/doi.org\/10.1016\/j.stem.2008.08.001.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"3080_CR183","doi-asserted-by":"publisher","first-page":"973","DOI":"10.2353\/ajpath.2006.050416","volume":"168","author":"C Hu","year":"2006","unstructured":"Hu C, Di\u00e9vart A, Lupien M, Calvo E, Tremblay G, Jolicoeur P. Overexpression of activated murine Notch1 and Notch3 in transgenic mice blocks mammary gland development and induces mammary tumors. Am J Pathol. 2006;168(3):973\u201390. https:\/\/doi.org\/10.2353\/ajpath.2006.050416.","journal-title":"Am J Pathol"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-026-03080-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-026-03080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:44:01Z","timestamp":1791852241000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-026-03080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":183,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3080"],"URL":"https:\/\/doi.org\/10.1186\/s12964-026-03080-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,17]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"547"}}